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Linking functions: an additional 
role for an intrinsically disordered 
linker domain in the transcriptional 
coactivator CBP
Sara Contreras-Martos1,2, Alessandro Piai3,4, Simone Kosol1,2,5, Mihaly Varadi  1,2,6, Angela 
Bekesi1,2, Pierre Lebrun1,2, Alexander N. Volkov1,2, Kris Gevaert7,9, Roberta Pierattelli  3,4, 
Isabella C. Felli  3,4 & Peter Tompa1,2,8
The multi-domain transcriptional coactivators CBP/p300 integrate a multitude of signaling inputs, 
interacting with more than 400 proteins via one or more of their globular domains. While CBP/p300 
function is typically considered in terms of these structured domains, about half of the protein consists 
of intrinsically disordered regions (IDRs) of varying length. However, these IDRs have only been thought 
of as linkers that allow flexible spatial arrangement of the structured domains, but recent studies have 
shown that similar IDRs mediate specific and critical interactions in other proteins. To examine the roles 
of IDRs in CBP, we performed yeast-two-hybrid screenings of placenta and lung cancer cDNA libraries, 
which demonstrated that the long IDR linking the KIX domain and bromodomain of CBP (termed ID3) 
can potentially bind to several proteins. The RNA-binding Zinc-finger protein 106 (ZFP106) detected 
in both libraries was identified as a novel substrate for CBP-mediated acetylation. Nuclear magnetic 
resonance (NMR) spectroscopy combined with cross-linking experiments and competition-binding 
assays showed that the fully disordered isolated ID3 transiently interacts with an IDR of ZFP106 in a 
fashion that disorder of both regions is maintained. These findings demonstrate that beside the linking 
function, ID3 can also interact with acetylation substrates of CBP.
CREB-binding protein (CBP) and its homolog histone acetyltransferase p300 (p300) are multi-domain transcrip-
tional regulators involved in diverse biological functions such as cell cycle, proliferation, differentiation, home-
ostasis, and apoptosis1, 2. Their function is mainly based on their interaction with a large variety of transcription 
factors and other regulatory proteins targeting their intrinsic histone acetyl transferase (HAT) activity on the 
chromatin and a broad range of partner proteins3, 4. Mutations affecting CBP/p300 genes have been implicated 
in Rubinstein-Taybi syndrome and several types of cancer, emphasizing their central role in orchestrating gene 
regulation2, 3.
CBP/p300 are about 2400 residues in length and contain several highly conserved domains and motifs, such 
as zinc-finger motifs PHD, RING, TAZ1, TAZ2 and ZZ, the CREB binding (KIX) domain, nuclear receptor 
coactivator binding domain (NCBD), bromodomain and HAT domain. Long intrinsically disordered regions 
(IDRs, Fig. 1a) connect the structured domains that mediate interactions with more than 400 partner proteins1. 
Although intrinsically disordered proteins/regions of proteins (IDPs/IDRs) have frequently been implicated in 
protein-protein interactions5, the function(s) of the IDRs in CBP/p300 has never been investigated in detail. 
Rather, it has been suggested that their role is to “connect” the folded, functional elements, enabling CBP/p300 to 
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engage with distinct patterns of chromatin-bound transcription factors in assembling large signaling complexes, 
such as the enhanceosome6. However, it would be quite surprising if about half of the protein primary sequence 
would only have the function of “connecting” globular functional domains, and therefore it is likely that a variety 
of different unexplored functional roles are encoded in those long disordered regions. The N- and C-terminal 
IDRs in CBP/p300 may also enable long-range structural/functional communication within the protein, as exem-
plified by the repression of HAT activity by phosphorylation of N-terminal Ser 89 in p3007. HAT activity and sub-
strate specificity are also regulated by the flanking domains of HAT (bromodomain, PHD, RING, ZZ and TAZ2 
domain) through intramolecular interactions8.
To assess the possible binding and regulatory role(s) of IDRs in CBP/p300, we are conducting systematic 
studies on the structural state and binding function of the IDRs of CBP, including ID3 (located between the KIX 
domain and bromodomain), ID4 (located between the TAZ2 domain and NCBD domain)9 and ID5 (located at 
the C-terminal end of the molecule, past the NCBD domain; cf. Fig. 1a). Our ultimate aim with these studies is 
to develop a comprehensive structural-functional model of CBP/p3009, 10, that also includes the role(s) of IDRs 
and their interplay with globular domains. No specific interaction has been mapped to any of these regions yet6, 11. 
For ID3, we identified several potential new interaction partners in yeast two-hybrid (Y2H) screenings, among 
them the Zinc-finger protein 106 (ZFP106). Recent studies suggest that this nuclear protein, ZFP106, is involved 
in RNA processing and it has been associated with neuromuscular and neurodegenerative disorders12–15 such 
as amyotrophic lateral sclerosis (ALS). We identified ZFP106 as a novel substrate of CBP-mediated acetylation. 
Active, full-length CBP acetylated ZFP106 on several lysines residues located in two main clusters. The transient 
Figure 1. Domain 3 (ID3) of CBP is fully disordered. (a) CBP domain organization. CBP globular domains 
(colored; Br: Bromodomain, R: Ring) are connected by intrinsically disordered regions (IDRs, grey) of different 
lengths. The intrinsically disordered region 3 (ID3, aa674–1080) is located between the KIX domain and 
bromodomain of CBP. (b) Neighbor corrected structural propensities (ncSP) obtained from experimentally 
measured N, C′, Cα and Cβ chemical shifts. Positive and negative values correspond to α-helical and β-sheet 
propensities, respectively. (c) SAXS Kratky plot also shows an overall disordered state, with a minor tendency 
for local secondary structure formation. (d) Ensemble of selected conformations ID3 may adopt in solution. 
(e) Rg distributions of a random pool of ID3 conformations (teal), of the pool of ID3 conformations biased 
by experimental ncSP scores (grey) and the ensemble calculated by Flexible Meccano and selected by GAJOE 
(green).
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interaction between the two IDRs was confirmed by a combination of competition-binding assays, cross-linking 
experiments and NMR spectroscopy. Finally, we determined the regions of ID3 and ZFP106 involved in the fuzzy 
interaction by employing paramagnetic relaxation enhancement (PRE) NMR spectroscopy.
Results
ID3 is fully disordered. Although bioinformatics predictions suggest that ID3 is an IDR, its structural prop-
erties have never been experimentally characterized. To this end, we carried out the structural characterization of 
the domain by several techniques in reducing buffer at physiological salt concentration. Both in SDS-PAGE and 
size-exclusion chromatography (SEC), the apparent molecular weight (Mw) of ID3 is about 70 kDa, two times its 
actual Mw, which is often the first indication of structural disorder16. In far-ultraviolet (UV) circular dichroism, 
ID3 has a strong negative peak around 200 nm, typical of random coil proteins, with a slight tendency to local sec-
ondary structure formation16 (Supplementary Fig. S1b). Lack of long-lasting structural elements in ID3 allowed 
the employment of a heat-treatment step17 in the protein purification protocol, which increases the purity and 
stability of the sample. This was confirmed by comparing circular dichroism and 2D 1H-15N NMR spectra of ID3 
obtained with and without this step (cf. Supplementary Fig. S1b and S1c), no significant difference between the 
two samples could be observed. Solution NMR has become the preferred technique for studying IDPs/IDRs18, 19 
as it allows a detailed structural analysis of the polypeptides. To achieve the essentially complete sequence specific 
assignment (about 95%) of the 407 residues of ID3, including its 75 prolines (18%), the recently developed NMR 
strategy to study complex IDPs, which combines 1H and 13C detected high-resolution multi-dimensional NMR 
experiments18, 20–22 was necessary (Supplementary Fig. S1a and Tables S1 and S4). The chemical shift (CS) assign-
ment of this disordered domain was facilitated by acquiring additional experiments on a shorter N-terminal 
fragment of ID3 (ID3-F1 from residue 674–848), which were used also to validate the assignment of the full-
length linker. NMR was also used to characterize ID3 backbone dynamics by measuring 15N R1, 15N R2 relaxation 
rates and heteronuclear 1H-15N NOE values (hetNOE) (Supplementary Fig. S2). The domain showed high local 
mobility on the picoseconds to nanoseconds timescale within residue 725–750 and 775–800, displaying higher 
1H-15N hetNOE and 15N R2 values, which indicate slightly more structured conformations than in the rest of the 
polypeptidic chain. Furthermore, the scattered 15N R2 values for some residues in the N-terminal region indicate 
the occurrence of some exchange processes18. Secondary-structure propensities (ncSP)23 calculated from exper-
imental CS values24 suggested short regions of isolated transient α-helices (in the N-terminal half; approximate 
residue 674–874) or extended β-type conformations (in the C-terminal third; approximate residue 974–1080), 
highlighting the presence of potential binding sites (Fig. 1b).
The structural properties are different from those of ID49, for which two segments showing significant 
α-helical propensity were detected, indicating that each linker has specific structural and dynamic properties that 
are likely to have an impact on their function.
SAXS measurements [following removal of potential aggregates by high-pressure liquid chromatography 
(HPLC)] yielded an average radius of gyration (Rg) of 80 Å of the different conformers in solution (Fig. 1c and e), 
corresponding to a disordered state.
Ensemble description of ID3 structure. To investigate potential pre-formed structural elements in ID325, 
we combined data from SAXS and NMR experiments and calculated an ensemble of possible conformations that 
ID3 can adopt in solution. To this end, Flexible-Meccano was used with NMR-derived ncSP (Fig. 1b) as con-
straints to generate a random semi-pool of 9876 conformers26. For every conformer, theoretical SAXS scattering 
curves were calculated, compared to the experimental SAXS data and used for selecting the best fitting ensemble27  
(Fig. 1d; for the fit between the experimental SAXS data and the selected pool, see Supplementary Fig. S3a). 
We observed a preference in the ensemble for more extended conformers, with a shift towards higher Rg values 
(Fig. 1e). Short dispersed α-helices observed in the ensemble (Fig. 1d) correspond to secondary structure ele-
ments derived from the ncSP input (Fig. 1b).
Potential binding motifs in the disordered ensemble of ID3. In order to highlight the potential 
role of ID3 in mediating protein-protein interactions, we also analyzed characteristic features of the sequence 
(Supplementary Fig. S4). In general, about half the residues of ID3 fall into potential binding sites predicted by 
ANCHOR28 and about half the sequence is highly conserved by DisCons29, suggesting the presence of multi-
ple interaction sites within this disordered region of CBP. Several moderately populated helical regions in the 
N-terminal half appear as potential preformed binding sites, e.g. the highly conserved helical segment around 
residues 824–844 is predicted as a potential molecular recognition feature (MoRF). C-terminal regions of β pro-
pensity are highly conserved and have a conspicuous enrichment of post-translational modification (PTMs) 
sites, suggesting functional regulation of this region. The DynaMine30 profile also shows peaks in this region 
(Supplementary Fig. S4, underlined), which together predispose this region for mediating interaction(s) probably 
not based on induced folding31.
ID3 potentially interacts with several proteins. To find out if ID3 mediates protein-protein inter-
actions, we applied a Y2H screening on two different cDNA libraries, one from human placenta (important 
for its broad spectrum of expressed genes) and another from human lung cancer (useful to observe potential 
disease-related interactions). We expected that besides general, housekeeping proteins, shared partners in the two 
different libraries may point to functionally important and potentially disease-associated interaction partners of 
CBP/p300 mediated by ID3, mitigating the effect of known high false positive hit rates of Y2H. A total of 37 pro-
teins were classified as potential ID3 binders, including 4 candidates that have already been described to interact 
with CBP or p300 (HIPK132, PIAS133, PAIS334 and TDG35) (Fig. 2a). Surprisingly, sequence analysis of the inter-
acting fragments and full-length proteins highlighted a preference of ID3 for binding disordered regions within 
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interacting partners (Fig. 2b; for the statistical test indicating significance preference, see Supplementary Fig. S3b). 
Importantly, about half of the identified protein partners were involved in processes related to protein biogenesis, 
such as gene transcription, pre-mRNA maturation and protein biosynthesis. Among those, we decided to further 
investigate the transcriptional regulator ZFP106 (Q9H2Y7), because its role in immune response, muscle differ-
entiation, DNA damage, splicing and motor and sensory neuron survival14, 36. Further, ZFP106 and CBP may be 
co-localized in nuclear speckles and be part of a larger complex regulating mRNA production or maturation12, 37, 38. 
ZFP106 was identified in both libraries and structural disorder is involved in recognition in both binding part-
ners. In the placenta library, residues 1265–1521 of ZFP106 were identified, whereas a second, overlapping frag-
ment (residue 1007–1448) was found in the lung cancer library (this clone was frame-shifted, which is probably 
compensated by translational frame-shift in yeast). Only one copy was found in each library, which is consistent 
with the low expression levels of ZFP106 in the respective tissue types38. For the detailed characterization of the 
ID3 – ZFP106 interaction, the shorter fragment 1265 to 1521, denominated as ZFP106-f, was selected.
The transcriptional regulator ZFP106 is acetylated by full-length CBP. CBP/p300 have recently 
been reclassified as lysine acetyltransferase 3 (KAT3) that can acetylate interacting protein partners, primarily 
transcription factors or coactivators1. To probe such a functional consequence of the interaction between CBP 
Figure 2. ID3 interacts with the transcription factor ZFP106. (a) Potential interaction partners of ID3 have 
been identified by a yeast 2-hybrid (Y2H) screen. Y2H interactions were classified according to the libraries 
in which they were detected: placenta (pink), lung cancer (blue), or both (black underlined). Four proteins 
have been described in previous studies to interact with one or more of the CBP’s globular domains32–35 
(bold). ZFP106, selected for further studies, is marked in white. (b) Potential interactors were analyzed for 
their structural content (Structured: more than 60% of its sequence predicted to be structured; Disordered: 
more than 60% of its sequence predicted to be disordered; Half D/S: the rest; *Statistically significant preference 
of ID3 for binding disordered regions) and for their function. Disorder predictions were carried out with the 
IUPred webserver70, whereas gene ontology (GO) annotations and available literature were used to classify the 
proteins in four main groups: Protein biogenesis (including transcription, pre-mRNA maturation and protein 
biosynthesis), DNA damage, Apoptosis and Others.
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and ZFP106, we assayed the acetylation of ZFP106-f with active, full-length CBP. The reaction was performed in 
HAT assay buffer in the presence of reducing agents, at low protein concentrations. Western blot (WB) analysis 
with anti-acetylated-lysine antibody showed a band for the 50 kDa ZFP106-f, revealing ZFP106 as a novel sub-
strate of CBP (cf. Fig. 3).
By MS, no basal acetylation (prior to CBP addition) of the ZFP106-f sample was detected, whereas CBP tar-
geted lysines primarily within two main hot-spots in the C-terminal half of the protein, acetylating only ten 
lysines out of twenty-four (in about 5–10% of the population) (Fig. 3a). For the complete MS sequence cover-
age, two MS analyses (FL-1 and FL-2) were needed as each independent analysis covered only 62% and 90% of 
ZFP106-f amino acid sequence (Fig. 3d).
Figure 3. ZFP106 is specifically acetylated only by full-length CBP. (a) ZFP106-f was acetylated by either 
full-length (FL) or the catalytic core domain (CD) of CBP under comparable conditions, and the sites of 
acetylation were determined by MS. Specific acetylation pattern by full-length CBP (blue) is in contrast to the 
indiscriminate acetylation achieved by the core domain (orange). *Location of the lysine rich patch of ZFP106-f. 
(b) SDS-PAGE and WB developed with anti-acetylated-lysine antibody of ZFP106-f acetylated by the full-
length or core domain of CBP. (c) Western blot developed with anti-acetylated-lysine antibody of histone 4 (H4) 
acetylated by the full-length or core domain of CBP. Time points of the reaction are presented and highlight 
a much higher activity for the CD compared to the FL enzyme. (d and e) The ratio of acetylated peptides 
corresponding to various lysines identified by MS using ZFP106-f (d) or H4 (e) as a substrate, acetylated with 
full-length CBP (dark blue: first MS analysis; light blue: second MS analysis) or its core domain (orange).
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Acetylation of ZFP106-f by the CBP core domain alone is efficient but nonspecific. In order to 
determine if the targeting of lysine acetylation of ZFP106-f required specific protein-protein interaction in the 
context of full-length CBP, we compared the acetylation pattern of ZFP106-f and histone H4 (the classic CBP 
substrate) by the core domain (which contains the active HAT domain plus flanking small, globular domains: 
bromodomain, PHD, RING, ZZ and TAZ2, cf. Fig. 1a) and full-length CBP. Acetylation by the core domain 
reaches saturation much faster than acetylation by full-length CBP (e.g. H4 acetylation, Fig. 3c). With H4, there 
are already some differences between the ratio of acetylation of specific (functional N-terminal tail, K6 to K32) 
and non-functional (apparently non-functional, K78 to K92) lysines by the core domain and full-length CBP, 
i.e. full-length CBP has some capacity to discriminate between specific and non-specific sites. When ZFP106-f 
acetylation is studied this discrimination is much stronger; the core domain acetylates all the lysines available, 
while full-length CBP acetylating only a subset of them (about 10/24, Fig. 3a and d). Thus, the modification by the 
core domain can be considered indiscriminate, whereas by the full-length CBP “specific”. This can be interpreted 
as substrate targeting via specific protein-protein interaction between ZFP106-f and full-length CBP, involving 
its ID3 region.
Interaction of ID3 and ZFP106 assessed by competition-binding. The discovery of ZFP106-f 
as a novel substrate of CBP-mediated acetylation allowed us to ascertain the interaction of ID3 and ZFP106-f 
via competition-binding assays. To investigate the interaction in more detail, we carried out the competition 
assay by titrating recombinant ID3 into the acetylation reaction with active, full-length CBP. The free ID3 was 
found to compete with the ID3 of full-length CBP for binding the substrate, ZFP106-f, causing a significant 
concentration-dependent decrease in the acetylation of ZFP106-f (Fig. 4a). To provide evidence for the specificity 
of the interaction, we repeated the competition assays with an excess of ID3 of “scrambled” sequence, scrID3 
(maintaining the original amino acid composition), which is an approach often used to provide evidence for 
the specificity of interactions of IDPs31. Scrambling abrogates all possible sequence-specific interaction, while 
maintaining the ones that only derive from physical features relying on amino acid composition. In addition, we 
generated an ID3 deletion mutant lacking the C-terminal region (ID3delCTR) (Supplementary Fig. S5), since 
this region was found to interact with ZFP (cf. section “Dissecting the fuzzy ID3-ZFP106-f interaction”). This 
construct also fails to have an impact on the acetylation level of ZFP106-f (Fig. 4a and Supplementary Fig. S5). 
Furthermore, in another control experiment with H4 as a substrate, ID3 did not induce a reduction of H4 acetyl-
ation, excluding the possibility that ID3 might directly inhibit CBP-HAT activity or bind to another CBP domain 
and alter its catalytic activity (Fig. 4a and Supplementary Fig. S5). Overall, these results show that ID3 specifically 
binds to ZFP106-f via defined sequence features.
Fuzzy interaction of ID3 with the transcriptional regulator ZFP106. In silico analysis and circular 
dichroism experiments (Fig. 5) showed that ZFP106-f is also largely disordered, which suggests a rather transient 
binding between the two IDRs that can occur either via a mutual (synergistic) folding39 or a “fuzzy” interaction31, 
in which both IDRs remain largely disordered. In fact, Y2H experiments are particularly suitable for detect-
ing transient protein interactions40, whereas in co-IP and SEC experiments no strong or stable interaction was 
detected. Circular dichroism measurements confirmed the fuzziness of the complex, in which neither of the 
partners undergoes major structural rearrangements upon association (Fig. 5b). Next, we applied cross-linking 
with BS3 (bis(sulfosuccinimidyl)suberate)41 to capture the transient interaction of GST-tagged ID3 (or free GST 
as control) and His-tagged ZFP106-f (Fig. 4b). We observed on SDS-PAGE the formation of high-Mw complexes 
in which the presence (and thus interaction) of both protein partners was proven by two consecutive Western 
blots (with a membrane stripping step in between) with anti-His and anti-GST antibody to visualize high-Mw 
overlapping bands (box). It should be noted that in these experiments the Mw of cross-linked bands does not 
correspond to the sum of the Mw of the individual proteins, because cross-linked protein products migrate anom-
alously on the gel, as previously described42. In addition, ZFP106-f appears to be intermolecularly crosslinked to 
form homodimers of higher apparent Mw (about 115 kDa for a dimer of 80 kDa), and also intramolecularly, in 
multiple different ways, causing the band to appear as a smear of heterogeneous apparent Mw population (as a 
consequence of the high number of lysine residues in the protein). Specificity of the cross-linking was assessed 
in our control reaction (C), where under the same conditions no complex formation between GST and ZFP106-f 
could be observed (Fig. 4b and Supplementary Fig. S6).
Dissecting the fuzzy ID3 - ZFP106-f interaction. To identify the residues of ID3 involved in the inter-
action with ZFP106-f, 2D 1H-15N NMR spectra of ID3 were recorded in the presence of increasing amounts 
of ZFP106-f. Only very minor and dispersed chemical shifts (CS) perturbations could be observed along 
the ID3 sequence (Supplementary Fig. S7a). Given the other lines of evidence for the interaction of the two 
proteins, this can be interpreted in terms of a fuzzy interaction with dispersed and heterogeneous interfaces 
between the two proteins. CS is not sensitive to this type of interaction, because measured CS values are linear, 
population-weighted averages of all protein species and conformations.
Therefore, to better characterize the interaction of the two proteins, we turned to paramagnetic resonance 
enhancement (PRE) measurements. By paramagnetically tagging one of the interaction partners, residues close 
to the interaction site of the second protein can be detected by decreases in signal intensity. Because PRE effects 
are averages weighted by the <r−6> -dependence of the paramagnetic effect, even a minor population with 
shorter distance between the nuclei and the paramagnetic probe (r) can have a larger - and thus observable - 
contribution to the signal measured43, 44. To outline the ID3 and ZFP106 regions involved in the interaction, 
PRE NMR experiments were carried out by labeling ZFP106-f at three different positions (M1, M2, M3) with an 
EDTA(Mn2+)-based paramagnetic tag (Fig. 6a) (for the diamagnetic references, wt ZFP106-f was used for the 
entire set of experiments).
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The PREs observed with the three ZFP106-f constructs confirmed the interaction and highlighted two signifi-
cantly affected ID3 regions, one in the N-terminal region (NTR, 674–780) and the other in the C-terminal region 
(CTR, 999–1050) (Fig. 6b). However, interaction with the NTR of ID3 is seen throughout all the PRE NMR 
experiments, irrespectively of the paramagnetic probe attachment site, and was also observed with an unrelated 
IDR (control experiment), human calpastatin domain 1 (hCSD1), tagged with the same paramagnetic probe 
(Fig. 6b and Supplementary Fig. S7e). The very same NTR region is the one mostly affected by chemical exchange 
as revealed by the high R2 values (Supplementary Fig. S2b). Therefore, we concluded that the interaction with 
NTR is nonspecific. Further corroboration came with additional control experiments, in which the paramagnetic 
label free in solution (upon reduction of the disulfide bond between ZFP106-M2-cys and the label) also gave 
rise to same type of nonspecific signal in NTR of ID3, whereas it did not affect the signal at the CTR, confirming 
that the observed effects at the CTR of ID3 are due to the specific interaction of the two proteins (Supplementary 
Fig. S7d).
Moreover, the interacting region(s) of ZFP106-f can be delineated from the different effects the presence of the 
three ZFP106-f constructs has on ID3 signal intensities in the 2D 1H-15N NMR spectra (Fig. 6b). A strong signal 
decrease was observed with the ZFP106-f-M2, and much weaker effect with ZFP106-f-M1. The paramagnetic 
Figure 4. ID3 –ZFP106-f interaction assessed by competition binding assay and cross-linking. (a) Top: 
Competition assays with ZFP106-f as a substrate demonstrate that recombinant ID3 competes with ID3 in the 
full-length CBP for binding ZFP106-f, which results in a decrease of the ZFP106-f acetylation in the presence 
of an excess of ID3. However, addition of the same amount of scrambled ID3 (scrID3) has no effect. Bottom: as 
a control, the same experiment was run using histone 4 (H4) as a substrate; no change in H4 acetylation level 
could be detected after addition of an excess of ID3. Acetylation was followed by anti-Ac-Lys antibody, adding 
ID3 to the acetylation reaction in an excess of 10, 100 or 150 times to full-length CBP (18.5 pmol) and its effect 
was also compared to that of scrambled-ID3 (scrID3; control reaction) (C+: control reaction). (b) Cross-linked 
ZFP106-ID3 complex (S: sample reaction) is shown by the presence of high-Mw overlapping bands in the SDS-
PAGE gel after cross-linking, anti-His WB and anti-GST WB (box). Under similar condition, ZFP106-GST (C: 
control reaction) were not cross-linked. Cross-linked complexes formed during the reaction are detailed on the 
right side of the WB and they have been determined by comparing signals between the anti-His and anti-GST 
WB (GST 25 kDa; ZFP106-f 40 kDa; GST dimer 62 kDa; ID3 100 kDa, ZFP106-f dimer 115 kDa, ZFP106-f – ID3 
complex above 170 kDa).
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tag sites M1 and M2 are in relative close proximity to each other (Fig. 6a). In contrast, ZFP106-f-M3 caused 
no change in signal intensity in the CTR of ID3, suggesting an interaction site between residues 1300–1400 of 
ZFP106 (Fig. 6).
Interestingly, the region following the M2 label in ZFP106-f is enriched in lysines and carries a positive net 
charge, whereas the CTR of ID3 is highly negatively charged (Fig. 6c), indicating an electrostatically driven inter-
action. This was confirmed by NMR experiments performed in the presence of salt, which showed that at 150 mM 
NaCl the PRE effect was significantly reduced (Supplementary Fig. S7b and S7c). Specificity of the interaction 
could be concluded, though, from i) a still detectable binding at physiological salt concentrations, and ii) cancel-
lation of the PRE effect on the CTR (but not by NTR) upon the application of DTT, which removes the paramag-
netic label from the protein (Supplementary Fig. S7d).
In all, these PRE experiments provided evidence for a transient electrostatic interaction between the two 
proteins mediated by the negatively charged CTR of ID3 and a positively charged lysine-rich patch in the middle 
of ZFP106-f.
Discussion
CBP is a multi-domain transcription coactivator that mediates and integrates the action of hundreds of transcrip-
tion factors and coactivators, which interact with its globular domains and target its activity on the chromatin 
and/or other proteins2, 6. The function of its long IDRs has been mostly described as that of passive linkers. Here, 
we focused our attention on possible additional roles of the 407 residues long ID3 located between the KIX 
domain and bromodomain of CBP.
SAXS, circular dichroism and NMR spectroscopy showed for ID3 a random coil state. By integrating 
1H-detected and 13C-detected high-resolution multi-dimensional NMR experiments18, 20–22 we assigned about 
95% of backbone chemical shifts, providing atomic resolution information on its structural and dynamic fea-
tures. An ensemble of possible conformations calculated with experimentally derived ncSP scores and SAXS 
data supported the presence of several potential binding sites with mild local helical or β propensities, within a 
largely disordered module. The extended and flexible conformations of ID3 are expected to favor functions/inter-
actions that take advantage of its dynamic properties. In accord, the specific binding role(s) of ID3 is supported 
by our Y2H studies in two cell-lines that uncovered dozens of potential ID3 binding partners. Among those, the 
transcriptional regulator ZFP106 was identified as a new acetylation substrate of CBP in vitro, which is in line 
with prior MS-based proteomic studies, which showed acetylation of ZFP106 on some of the lysine residues 
identified here (cf. PhosphoSitePlus45). The interaction of ZFP106-f with ID3 was confirmed by cross-linking 
and the observed competition between ID3 and full-length CBP in the acetylation reaction. Specificity of the 
interaction is underscored by the highly nonspecific acetylation of ZFP106-f by the core domain of CBP, which 
also strongly acetylates the lysine-rich patch located in the middle of ZFP106-f. PRE experiments, at low and high 
salt concentration, allowed us to determine the ID3 – ZFP106-f interacting regions, which include an extended 
negative patch of ID3 (roughly, residues S980-P1080) and a mostly positive patch of ZFP106-f (roughly, residues 
P1340-K1395). These experiments together with the HAT competition assays, in which the C-terminal charged 
Figure 5. Fuzzy interaction between the two disordered regions. (a) Top: Disorder prediction of ZFP106-f 
using IUPred server indicates a high disorder tendency. Bottom: The ZFP106-f amino acid sequence used for 
the disorder prediction. (b) Circular dichroism spectra of ID3, ZFP106-f and 1:1 ratio of ID3:ZFP106-f. The 
spectrum of the complex resembles the individual spectra indicating no major changes in the structural content 
of the two partners upon association.
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region of ID3 has been deleted (Supplementary Fig. S5) confirmed the electrostatic nature of the interaction. The 
ZFP106-f lysine-rich patch involved in the interaction with ID3 is not acetylated by the full-length CBP, suggest-
ing that ID3-ZFP106-f interaction may be involved in targeting specific lysine acetylation of ZFP106-f by “hiding/
exposing” some ZFP106-f regions from/to the CBP-HAT domain. Specificity of this targeting relation is further 
corroborated by the similar behavior of H4, the archetypic substrate of CBP/p300. With H4, the core domain 
cannot distinguish between specific (N-terminal histone tails; K6 – K21) and nonspecific (K32 – K92) acetylation 
sites, whereas full-length CBP shows a strong preference for the former.
An intriguing aspect of our investigation is the transient character of this targeting interaction; such fuzzy 
and/or weak and transient complexes have been suggested to confer specificity without a structured state31, 46. 
For example, it has been shown that the weak, high-μM interaction of the cytoplasmic tails of T–cell receptors 
in T–cell signaling occurs via their disordered state, as suggested by circular dichroism and NMR47. The physio-
logical regulatory relevance of an even weaker (“ultraweak”) interaction has been demonstrated in focal adhesion 
dynamics. Here, the interaction of the SH3 domain of Nck2 and the LIM4 domain of PINCH-1 has a Kd of 3 mM, 
still it is indispensable in integrin signaling, as suggested by genetic evidence48. The importance of transient, 
Figure 6. CTR of ID3 specifically interacts with the middle region of ZFP106-f. (a) Representation of the 
ZFP106 fragment identified in the Y2H assay (blue) and the three positions (M1, M2 and M3) where a 
paramagnetic label was attached to the protein. (b) I(para)/I(dia) plots of the 2D 1H-15N HSQC cross-peaks 
intensities of ID3 in the presence of the paramagnetically tagged single-Cys ZFP106-f mutants M1, M2 and 
M3 showing the site of interaction within ID3 (red box). A control experiment with an unrelated IDP, domain 
1 of human Calpastatin (hCSD1), labeled with the same paramagnetic probe, is also shown to outline sticky 
region(s) of ID3 engaged in non-specific interaction (blue box). (c) Charge distribution plots of ID3 and 
ZFP106-f amino acid sequences calculated with the EMBOSS website (http://www.bioinformatics.nl/cgi-bin/
emboss/charge). The regions involved in the interaction are highlighted (red): the middle region of ZFP106-f 
close to the M2 site, and the C-terminal 100 residues (CTR) of ID3.
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lowly-populated states that are still invisible to most structural biology techniques has also been demonstrated in 
encounter complexes49, RNA-protein recognition50 and the catalytic cycle of dihydrofolate reductase51. However, 
we cannot exclude the possibility that other domains of CBP or ZFP might be also involved in the interaction and 
influence affinity. This is also corroborated by the ID3 competition experiments, in which ID3 in a large molar 
excess (10x, 100x) is required to compete with binding and targeting of ID3 region within full-length CBP.
It is worth mentioning that the identified interaction regions are also rather long and may contain spe-
cific interaction motifs or charge distribution required for the interaction. Especially, ID3 sequence presents 
a characteristic and regular distribution of charges that has been conserved during evolution (cf. Fig. 6c and 
Supplementary Fig. S4). Similar binding features may also be present in long IDRs of other multi-complex 
proteins, such as bacterial RNAse E52, BRCA153, or UPF254. Moreover, the observed acetylation of ZFP106-f 
fits perfectly with CBP/p300 function in general: CBP/p300 integrate the action of hundreds of transcription 
factors and coactivators, the function of which is often regulated by acetylation2, 3. In this context, the highly 
significant enrichment of ID3 binding partners for transcription-regulatory and DNA-binding functions is 
notable4. Moreover, “in vivo” acetylation of ZFP106 was previously described by Li Y. and colleagues in 2006. 
High-throughput MS analysis of acetylated proteins present in colorectal carcinoma cell lines (SNU-C2B) 
identified four acetylation sites in ZFP106 (K1350-ac, K13510-ac, K1352-ac, K1358-ac) (Record ID: 11618 in 
PhosphoSitePlus45) within a region that is comprised in our construct (AA1265–1521). Interestingly, in our in vitro 
experiments those sites seem only to be acetylated by the highly active and nonspecific core domain but not by 
the full-length CBP.
In a cellular context, ZFP106 and CBP share roles in developmental pathways and diseases such as cancer. 
They also share a number of interaction partners, such as the tumor suppressors APC (Adenomatous polypo-
sis coli protein) and Smad2 (Mothers against decapentaplegic homolog 2), which suggests that ZFP106 maybe 
involved in pathways such as TGFβ or Wnt signaling. In all, it seems reasonable that ZFP106 and CBP are part of 
a larger transcriptional complex that regulates expression of target genes involved in specific cellular processes, 
such as muscle cell differentiation or maintenance of the neuromuscular signaling12, 38, 55. Recent studies have 
shown that the nuclear ZFP106 protein that localized in nuclear speckles is required for normal assembly of the 
mammalian spliceosome, a process in which CBP/p300 also seems to participate12, 14, 56, 57.
In summary, our results suggest a possible additional role of an IDR in CBP, which may not only lead to a 
better description of the function of CBP/p300 and ZFP106, but also provides a precedence for addressing the 
function of long “linker” regions in large multi-domain signaling proteins.
Materials and Methods
Sequence analysis. A set of homologous ID3 amino acid sequences of various vertebrate species was assem-
bled to study disorder propensities, sequence conservation, and the presence of potential binding sites. Cf. SI 
Materials and methods.
Scrambling the sequence of human ID3. For control purposes, a scrambled-ID3 sequence sharing 21% 
identity with wt ID3 was generated. (Supplementary Fig. S8). SI Materials and methods.
Cloning, mutagenesis and recombinant proteins. Full-length CBP (UniProt id Q92793), core 
domain of CBP (residues 1095–1849); ID3 of CBP, (residues 674–1080); ID3-F1 of CBP (residues 674–848); and 
Cys-to-Ser mutant ID3(C845S) obtained by site-directed mutagenesis of Cys845 of ID3, were cloned from the 
full-length construct. ZFP106-f (residues 1265–1521 of full-length ZFP106 (UniProt Q9H2Y7)). Scrambled-ID3 
(scrID3), ID3delCTR and the three single-cysteine mutants of the ZFP106-f were cloned by GenScript (M1: 
C1472S (paramagnetic label on C1307), M2: insertion of Cys between Thr1346 – Arg1347 (paramagnetic label 
on insC1347*), M3: C1307S (paramagnetic label on C1472)). For further details, cf. SI Materials and methods.
Yeast two-hybrid screening. Y2H analysis was carried out by Hybrigenics Services S.A and described in 
SI Materials and methods. Identified partners were analyzed with IUPred (disorder level) and classified using GO 
annotation (biological process).
Recombinant protein expression, purification and labeling. Full-length (FL) CBP and its core 
domain (CD) were expressed in Sf9 cells, while the rest of the proteins were expressed in E. coli. Purification was 
achieved by a two- or three-step purification protocol including nickel (and Flag for the CBP constructs) affinity 
followed by size exclusion chromatography.
During ID3 purification a heat-treatment step of the lysate was done to increase the purity of the protein 
sample17, which was shown not to alter the secondary structure content of the protein (cf. Supplementary Fig. S1).
For the paramagnetic labeling, purified single-cysteine ZFP106-f mutants (M1, M2 and M3) and the hCSD1 
(for control experiment) were mixed with the metal-containing probe (thiol-reactive label pEDTA). The reaction 
was carried out overnight at RT and labeled proteins were re-purified. For further details, cf. SI Materials and 
methods.
Determination of the paramagnetic labeling by intact mass spectroscopy analysis. Intact pro-
tein masses were measured by direct infusion in a microelectrospray ionization ion trap mass spectrometer (LTQ 
XL). The mass spectra were deconvoluted using the software ProMass Deconvolution. For further details, cf. SI 
Materials and methods.
Circular dichroism spectroscopy. Far-UV circular dichroism spectra of ID3, ZFP106-f and the complex 
(1:1 molar ratio) were recorded on a J-715 spectropolarimeter in reducing buffer of physiological salt concentra-
tion. For further details, cf. SI Materials and methods.
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Small-angle X-ray scattering experiments. ID3 was injected into a size-exclusion column equilibrated 
with buffer of physiological salt concentration and SAXS data were collected continuously, selected frames corre-
sponding to the main protein elution peak were averaged using FOXTROT58 (buffer scattering subtracted), fol-
lowing data processing/analysis using ATSAS suite59 and calculation of the radius of gyration by PRIMUS QT60. 
For further details, cf. SI Materials and methods.
Nuclear magnetic resonance experiments (NMR) and data processing. All the experiments and 
acquisition parameters regarding ID3 sequence-specific assignment, backbone dynamics and, PRE experiments 
are reported in SI Materials and methods and Tables S1–S5.
Sequence-specific assignment. All the multidimensional NMR experiments for sequence-specific assignment 
were performed on uniformly [13C,15N] labeled ID3 and ID3-F1 in reducing buffer of physiological salt con-
centration at pH 6.5, with 10% D2O added for the lock. The CS assignment of ID3 has been deposited in the 
BioMagResBank (BMRB, http://www.bmrb.wisc.edu) as entry 26841. For further details, cf. SI Materials and 
methods.
Backbone dynamics. Backbone dynamics (at 297 K) of uniformly 15N-labeled ID3 were studied by using 15N 
relaxation data obtained from 2D 1H-15N HSQC-edited experiments61, carried out using a buffer of physiological 
salt concentration at pH 6.5, with 10% D2O added for the lock. For further details, cf. SI Materials and methods.
Paramagnetic relaxation enhancement (PRE) experiments. For the PRE measurements, 2D 1H-15N HSQC spectra 
of the paramagnetic and diamagnetic samples were acquired62 on [13C,15N] ID3(C845S) and 1 molar equivalent 
(eq) of single-Cys ZFP106-f mutant EDTA(Mn2+)-tagged (paramagnetic samples). The diamagnetic references 
were done with wt ZFP106-f with DTT added (wt proteins are equivalent to their EDTA(Zn2+)-tagged version for 
PRE referencing62). The unrelated protein control experiments were done with 1 eq of wt hCSD1-EDTA(Mn2+) 
(paramagnetic sample) or wt hCSD1 (diamagnetic sample, DTT added). The reduced-label control experiments, 
the [13C,15N] ID3(C845S):ZFP106-f-M2 sample was measured in absence and presence of reducing agents (DTT). 
All NMR samples were measured at pH 6.5 and 10% D2O for the lock, NaCl was added to a final concentration of 
150 mM. For further details, cf. SI Materials and methods.
NMR data processing. NMR data sets were processed using Bruker TopSpin 1.3 software or nmrPipe63. NUS data 
sets were converted with nmrPipe and then processed using either the Multidimensional Fourier Transform (MFT) 
or the Sparse MFT (SMFT) algorithm. Both programs are available at http://nmr.cent3.uw.edu.pl. Data analysis 
was done with Sparky64 or CcpNmr Analysis65.
Secondary structure propensity calculation. Secondary structure propensity analysis was calculated 
from C′, Cα, Cβ and N chemical shifts (95% assigned) by using the neighbor-corrected structural propensity calcu-
lator (ncSP) tool66. For further details, cf. SI Materials and methods.
Ensemble modelling. Ensemble models of ID3 were based on the combination of SAXS data and ncSP 
derived from experimental chemical shift values. Flexible-Meccano26 and SCCOMP67 were used to generate a 
pool of 9876 semi-random conformations (with side-chains modeled). Then, CRYSOL27 and the GAJOE algo-
rithm were employed27 to select subsets of the random pool that that agreed with the experimental SAXS data. For 
further details, cf. SI Materials and methods.
Acetylation Assay. In vitro ZFP106-f or H4 acetylation assays were performed in reducing buffer of phys-
iological salt concentration at 20 or 30 °C using FL or CD of CBP. For the HAT competition assay, x10, 100 
and 150 molar excess (relative to full-length CBP) of ID3, scrID3 and ID3delCTR were added to the acetyla-
tion reactions. The reactions were completed to saturation and the samples were analyzed by Western blot by 
anti-acetylated-lysine (Bioke) and anti-His (Sigma-Aldrich) antibodies. For the identification of acetylation sites, 
the proteins in solution were desalted and digested with either pepsin or endoglu-C, and analyzed by LC-MS/
MS in a microelectrospray ionization ion trap mass spectrometer (LTQ XL, or Orbitrap XL) as described68, 69. For 
further details, cf. SI Materials and methods.
Cross-linking Assay. Proteins were mixed in approximate 1:1 ratio (concentrations adjusted by SDS-PAGE). 
Cross-linking reactions were carried out for 15 min at RT in PBS with 1 mM DTT (S: sample, ID3:ZFP106-f; C: 
control, GST:ZFP106-f). Crosslinker BS3 was added to a final concentration of 0.25 mM. For further details, cf. SI 
Materials and methods.
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